Vasu Rangadass, Founder and Strategy Officer at L7 Informatics, and Jordan Lateiner of Syndax lead a panel on the evolution of the PMO from a project tracking function to a strategic enterprise partner. As pharma and biotech organizations recognize the strategic importance of execution excellence, PMOs are being asked to take on expanded roles in portfolio strategy, organizational change, and digital transformation.
The panelists will share their experiences scaling PMO capabilities, including how to build credibility with senior leadership, expand the PMO's mandate from project oversight to strategic portfolio management, and develop the talent and tools needed to operate as a true enterprise function. The discussion will cover the organizational, cultural, and political challenges of this transformation.
This session is particularly valuable for PMO leaders who are navigating the transition from operational to strategic positioning and want to learn from organizations that have successfully made this journey.
Minutes will be published after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
This section will be populated during/after the session.
Reflect on how this session's insights apply to your role. Sign in to add personal notes.
How does this session connect to your responsibilities? Sign in to capture personal relevance notes.
Track
Drug development, clinical trial management, regulatory submission
Jordan Lateiner
Rebecca Watson, Riyesh Menon
Gautam Pangu